Response to Zhou et al.

Journal of Clinical Investigation

Volumn 116, Issue 10, 2006, Pages 2564-

  Pascussi, Jean Marc ^a,b   Maurel, Patrick ^a   Vilarem, Marie José ^a  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CITCO; CONSTITUTIVE ANDROSTANE RECEPTOR; CYP24 ENZYME; CYTOCHROME P450; HORMONE RECEPTOR STIMULATING AGENT; PHENOBARBITAL; PHENYTOIN; PREGNANE X RECEPTOR; RIFAMPICIN; SR 128123; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

CELL CULTURE; DOWN REGULATION; DRUG RECEPTOR BINDING; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; HUMAN; LETTER; LIVER CELL; LONG TERM CARE; OSTEOMALACIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANTICONVULSANTS; CARBAMAZEPINE; GENE EXPRESSION; HUMANS; OSTEOMALACIA; PHENOBARBITAL; PHENYTOIN; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; STEROID HYDROXYLASES; TRANSCRIPTION FACTORS;

EID: 33749451211     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30017     Document Type: Letter

References (2)

1. Pascussi, J.M., et al. 2005. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J. Clin. Invest. 115:177-186. doi:10.1172/JCI200521867.
2. Zhou, C., et al. 2006. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J. Clin. Invest. 116:1703-1712. doi:10.1172/JCI27793.